2008
DOI: 10.4137/bmi.s840
|View full text |Cite
|
Sign up to set email alerts
|

Tracking Differential Gene Expression in MRL/MpJ versus C57BL/6 Anergic B Cells: Molecular Markers of Autoimmunity

Abstract: Background: Anergy is a key mechanism controlling expression of autoreactive B cells and a major site for failed regulation in autoimmune diseases. Yet the molecular basis for this differentiated cell state remains poorly understood. The current lack of well-characterized surface or molecular markers hinders the isolation of anergic cells for further study. Global gene profi ling recently identifi ed transcripts whose expression differentiates anergic from naïve B cells in model mouse systems. The objective of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 95 publications
1
3
0
Order By: Relevance
“…Additional support for the immunomodulatory role of the miR-17∼92 cluster in the identified regulatory circuit was obtained by the experimental validation that cluster members miR19b and miR-17, as well as miR-15a, target certain MAPKs with key roles in B cell immune signaling. More specifically, we found that miR-15a and miR-17 posttranscriptionally regulate MAPK8/ JNK, whereas miR-19b regulates MAP2K3, whose target is p38-MAPK; likely relevant to this discussion, the p38-MAPK signaling axis has been reported to regulate anergy in lupus-prone MRL mice (52). Altogether, our results suggest that the entire axis of MAPK signaling has a central role in anergy regulation in CLL subset #4.…”
Section: Discussionsupporting
confidence: 59%
“…Additional support for the immunomodulatory role of the miR-17∼92 cluster in the identified regulatory circuit was obtained by the experimental validation that cluster members miR19b and miR-17, as well as miR-15a, target certain MAPKs with key roles in B cell immune signaling. More specifically, we found that miR-15a and miR-17 posttranscriptionally regulate MAPK8/ JNK, whereas miR-19b regulates MAP2K3, whose target is p38-MAPK; likely relevant to this discussion, the p38-MAPK signaling axis has been reported to regulate anergy in lupus-prone MRL mice (52). Altogether, our results suggest that the entire axis of MAPK signaling has a central role in anergy regulation in CLL subset #4.…”
Section: Discussionsupporting
confidence: 59%
“…Residual B6 Tg spleen B cells are shortlived and fail to secrete anti-laminin Ig after endotoxin stimulation. This cell phenotype is preserved in the MRL/MpJ strain [21], although notably microarray analyses reveal strain differences in anergic B cell gene expression [23]. Thus, the LamH Ig Tg model provides a stable, well defined tolerance phenotype useful for the study of autoreactive B cell fates in the context of aggressive SLE models.…”
Section: Introductionmentioning
confidence: 99%
“…LG/J and MRL/MpJ are also models for autoimmune disease, although with late onset compared with mutant MRL/ MpJ-Fas lpr /Fas lpr mice (Shirai and Klinman 1994;Clark et al 2008). Interestingly, MRL/MpJ and LG/J display accelerated wound healing relative to other strains (Heber-Katz et al 2004;Blankenhorn et al 2009).…”
Section: Discussionmentioning
confidence: 99%